In the published report, V1AR promoted COX-2-dependent prostaglandin release from a mucosal mast in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, which was attenuated by conivaptan (a V1AR antagonist). This evidence concerns the gene AVPR1A and colitis.